Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
University of Michigan Rogel Cancer Center
Ohio State University Comprehensive Cancer Center
Incyte Corporation
M.D. Anderson Cancer Center
Ascentage Pharma Group Inc.
UNC Lineberger Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
OHSU Knight Cancer Institute
University of Nebraska
University of Nebraska
University of Nebraska
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Xencor, Inc.
Northwestern University
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
University Health Network, Toronto
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
Roswell Park Cancer Institute
Vanderbilt-Ingram Cancer Center
University of Maryland, Baltimore
Fred Hutchinson Cancer Center
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Maryland, Baltimore
University of Chicago
City of Hope Medical Center